LRRK2 and Parkinson disease: In PBMCs of sporadic PD patients, the level of LRRK2 expression in CD16+ monocytes, T cells, and B cells are higher compared with healthy controls, and the connection between inflammatory activity and monocyte LRRK2 levels is considerably different in patients’ PD [186].